Lorraine Blaise - Publications

Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 02, 2025

Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 18, 2025

Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study.

Journal: Hepatology international

Published: June 17, 2025

The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: May 28, 2025

Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: April 03, 2025

Comprehensive toolkit integrating lifestyle and clinical questionnaires with gut microbiota profiling via rectal swabs: application in intensive care cirrhotic patients.

Journal: Journal of medical microbiology

Published: March 06, 2025

Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: February 12, 2025

First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort.

Journal: JHEP reports : innovation in hepatology

Published: September 10, 2024

COVID-19 and chronic liver disease: results from the 1219 patients French registry.

Journal: Scientific reports

Published: July 25, 2024

Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studies.

Journal: JHEP reports : innovation in hepatology

Published: July 06, 2024

Prolonged survival in women with hepatocellular carcinoma: A French observational study.

Journal: Clinics and research in hepatology and gastroenterology

Published: July 01, 2024

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 21, 2023